Elinogrel potassium

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameElinogrel potassium
Drug Alias Nameelinogrelum依利格雷钾PRT-128PRT-060128PRT-060128-potassium
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsMyocardial InfarctionCardiovascular DiseasesRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[5
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionCardiovascular DiseasesRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG